Arca
Skip to content

Urinary tract infection

Drug research and approvals for urinary tract infection: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 99 studies of urinary tract infection are recruiting on ClinicalTrials.gov, Health Canada has authorized 7 drug trials for it since 2013, and the EU has 2 authorised medicines for it.

  • Recruiting worldwide: 99
  • Trials authorized in Canada: 7
  • FDA orphan approvals: 0
  • EU medicines: 2

Recruiting Now

Newest start dates first, of 99 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
Jun 7, 2023Antibiotic prophylaxis to prevent post-procedure uti after vcug (appruv)TRIMETHOPRIM / TRIMETHOPRIM-SULFAMETHOXAZOLEHAMILTON HEALTH SCIENCES CORPORATIONOngoing
Sep 23, 2021Andomized, double-blind, placebo-controlled, multicenter phase 3 study to assess the efficacy, safety and immunogenicity of vaccination with expec9v in the…VAC52416 (JNJ-78901563 [EXPEC9V])Johnson & JohnsonOngoing
Apr 28, 2021Prophylactic antibiotics following treatment of neurogenic overactive bladder with intradetrusor onabotulinumtoxina for the reduction of postoperative uti: a…CIPROFLOXACINGOVERNORS OF THE UNIVERSITY OF ALBERTAOngoing
Oct 7, 2020Prophylactic antibiotics during treatment of idiopathic overactive bladder with intradetrusor onabotulinumtoxina for the reduction of postoperative uti: a…CIPROFLOXACINGOVERNORS OF THE UNIVERSITY OF ALBERTAPending
Apr 25, 2019"canadian multicentre pilot open label study to evaluate the efficacy and safety of the bacterial vaccine uromune® in treating recurrent urinary tract…UROMUNEINMUNOTEK S.L.Pending
Jul 17, 2014A phase 3, randomized, double-blind, double-dummy, multicenter, prospective study to assess the efficacy and safety of eravacycline compared with levofloxacin…ERAVACYCLINETetraphase PharmaceuticalsOngoing
Aug 15, 2013A randomized controlled trial assessing the efficacy of antimicrobial prophylaxis for extracorporeal shock wave lithotripsy (swl) on reducing urinary tract…CIPROFLOXACINDR. HASSAN RAZVIOngoing

Medicines Authorised in the EU

Newest first
Nov 20, 2018Vaboremmeropenem;vaborbactamMenarini International Operations Luxembourg S.A.EMA ↗
Jun 23, 2016Zaviceftaceftazidime;avibactamPfizer Ireland Pharmaceuticals Unlimited CompanyEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.